scispace - formally typeset
D

Daniela Zugna

Researcher at Cancer Epidemiology Unit

Publications -  64
Citations -  2124

Daniela Zugna is an academic researcher from Cancer Epidemiology Unit. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 19, co-authored 58 publications receiving 1625 citations. Previous affiliations of Daniela Zugna include Örebro University & Karolinska Institutet.

Papers
More filters
Journal ArticleDOI

Mediation analysis in epidemiology: methods, interpretation and bias

TL;DR: The impact of the three main sources of potential bias in the traditional approach to mediation analyses are reviewed and discussed: (i) mediator-outcome confounding; (ii) exposure-mediator interaction and (iii) mediATOR- outcome confounding affected by the exposure.
Journal ArticleDOI

Preoperative Pelvic Floor Muscle Exercise for Early Continence After Radical Prostatectomy: A Randomised Controlled Study

TL;DR: Preoperative PFME may improve early continence and QoL outcomes after RP and further studies are needed to corroborate the results.
Journal ArticleDOI

The independent role of prenatal and postnatal exposure to active and passive smoking on the development of early wheeze in children

TL;DR: Maternal passive smoking exposure during pregnancy is an independent risk factor for wheeze in children up to the age of 2 years and pregnant females should avoid active and passive exposure to tobacco smoke for the benefit of their children's health.
Journal ArticleDOI

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

Pietro Quaglino, +65 more
- 01 Oct 2017 - 
TL;DR: This large multicenter retrospective study shows that there exist a large treatment heterogeneity in advanced MF/SS patients and differences between USA and non-USA centers but these were not related to survival, while the data reveal that chemotherapy as first treatment is associated with a higher risk of death and/or change of therapy and thus other therapeutic options should be preferable as firstreatment approach.